Werkgroep Cardiologische centra Nederland

PROMINENT (Follow-up)

Pemafibrate to reduce cardiovascular outcomes by reducing triglycerides in diabetic patients
Medicine
pemafibrate
Population
Diabetes mellitus
Phase
III
Starting year
2016
More information
Clinicaltrials.gov

Director of Study

dr. F.M.A.C. Martens (Cardioloog)
Deventer, Deventer Ziekenhuis